Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas (original) (raw)
- Letter
- Published: 16 February 1984
Nature volume 307, pages 658–660 (1984)Cite this article
- 435 Accesses
- 546 Citations
- 6 Altmetric
- Metrics details
Abstract
An important feature of the development of many human and animal tumours is the appearance of pre-malignant benign lesions, some of which undergo further changes during progression to malignancy1–4. Many of the currently accepted concepts of multi-stage carcinogenesis have been developed using an experimental model based on the chemical induction of tumours in mouse skin3,4. In this system, many of the pre-malignant papillomas which arise are promoter-dependent, and appear to regress if promoter treatment is interrupted, whereas others progress to form autonomous benign lesions and, in some cases, malignant carcinomas5. Although the number and nature of the events leading to malignancy are not known, DNA transfection experiments have led to the identification of several genes which may be qualitatively altered in tumour cells (see ref. 6 for review). We have previously shown that DNA from transplantable mouse skin carcinomas induced by chemical carcinogens has the ability to transform NIH/3T3 cells, and that the gene responsible for the transformation is an activated form of the mouse cellular Harvey-ras gene (c-_ras_H)7. We have now investigated the stage of carcinogenesis at which the proto-oncogene acquires transforming activity. We demonstrate that primary papillomas induced by chemical carcinogens in two different mouse strains have an activated c-_ras_H gene. This constitutes the first report of a benign tumour which contains DNA with detectable transforming activity. In addition, steady-state levels of c-_ras_H gene transcripts are elevated in the papillomas as compared with normal epidermis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Pierce, G. B. & Fennell, R. H. in Cancer Medicine (eds Holland, J. F. & Frei, E.) 149–167 (Lea & Febiger, Philadelphia, 1982).
Google Scholar - Knudson, A. G. Cancer Invest. 1, 187–193 (1983).
Article PubMed Google Scholar - Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. & Thielmann, H. W. (eds) Carcinogenesis Vol. 7 (Raven, New York, 1982).
- Boutwell, R. K. Crit. Rev. Tox. 2, 419–443 (1974).
Article CAS Google Scholar - Burns, F. J., Vanderlaan, M., Snyder, E. & Albert, R. E. Carcinogenesis Vol. 2 (eds Slaga, T. J., Sivak, A. & Boutwell, R. K.) 91–96 (Raven, New York, 1978).
Google Scholar - Cooper, G. M. Science 217, 801–806 (1982).
Article ADS CAS PubMed Google Scholar - Balmain, A. & Pragnell, I. B. Nature 303, 72–74 (1983).
Article ADS CAS PubMed Google Scholar - Digiovanni, J., Slaga, T. J. & Boutwell, R. K. Carcinogenesis 1, 381–389 (1980).
Article CAS PubMed Google Scholar - Hennings, H. et al. Cancer Res. 41, 773–779 (1981).
CAS PubMed Google Scholar - Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S. & Barbacid, M. Nature 298, 343–347 (1982).
Article ADS CAS PubMed Google Scholar - Der, C. J., Krontiris, T. G. & Cooper, G. M. Proc. natn. Acad. Sci. U.S.A. 79, 3637–3640 (1982).
Article ADS CAS Google Scholar - Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Nature 297, 474–478 (1982).
Article ADS CAS PubMed Google Scholar - Shimizu, K., Goldfarb, M., Perucho, M. & Wigler, M. Proc. natn. Acad. Sci. U.S.A. 80, 383–387 (1983).
Article ADS CAS Google Scholar - Pulciani, S. et al. Nature 300, 539–542 (1982).
Article ADS CAS PubMed Google Scholar - Balmain, A., Krumlauf, R., Vass, J. K. & Birnie, G. D. Nucleic Acids Res. 10, 4259–4277 (1982).
Article CAS PubMed PubMed Central Google Scholar - Tabin, C. J. et al. Nature 300, 143–149 (1982).
Article ADS CAS PubMed Google Scholar - Spandidos, D. & Kerr, I. B. Br. J. Cancer (submitted).
- Armitage, P. & Doll, R. Br. J. Cancer 11, 161–169 (1957).
Article CAS PubMed PubMed Central Google Scholar - Moolgavkar, S. H. & Knudson, A. G. J. natn. Cancer Inst. 66, 1037–1051 (1981).
Article CAS Google Scholar - Cook, P. J., Doll, R. & Fellingham, S. A. Int. J. Cancer 4, 93–112 (1969).
Article CAS PubMed Google Scholar - Reddy, E. P., Reynolds, R. K., Santos, E. & Barbacid, M. Nature 300, 149–152 (1982).
Article ADS CAS PubMed Google Scholar - Ellis, R. W. et al. J. Virol. 36, 408–420 (1980).
CAS PubMed PubMed Central Google Scholar
Author information
Author notes
- George T. Bowden: Division of Radiation Oncology, College of Medicine, University of Arizona, Tucson, Arizona 85724, USA
Authors and Affiliations
- Beatson Institute for Cancer Research, Garscube Estate, Bearsden Road, Glasgow, G61 1BD, UK
Allan Balmain, Martin Ramsden, George T. Bowden & John Smith
Authors
- Allan Balmain
You can also search for this author inPubMed Google Scholar - Martin Ramsden
You can also search for this author inPubMed Google Scholar - George T. Bowden
You can also search for this author inPubMed Google Scholar - John Smith
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Balmain, A., Ramsden, M., Bowden, G. et al. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas.Nature 307, 658–660 (1984). https://doi.org/10.1038/307658a0
- Received: 28 July 1983
- Accepted: 15 December 1983
- Issue Date: 16 February 1984
- DOI: https://doi.org/10.1038/307658a0